Answers are grounded in this paper and cite their sources.
Investigates the role of macrophages in hemophilic arthropathy, suggesting limited impact on acute synovitis.
BACKGROUND: Hemophilic arthropathy (HA) is a chronic joint disease caused by repeated joint bleeding in patients with hemophilia (PWH), leading to joint degeneration despite prophylactic treatment. The CX3CL1(fractalkine)-CX3CR1 chemokine axis regulates synovial lining macrophage function and has been implicated in inflammatory joint diseases including rheumatoid arthritis and osteoarthritis. OBJECTIVES: macrophages in experimental hemophilic arthropathy using genetic targeting and pharmacological inhibition. METHODS: knockout mice and the CX3CR1 non-competitive allosteric antagonist AZD8797. Outcomes were measured by changes in joint swelling after injury and histological assessment at Day 28 after injury for hemosiderin deposition and synovitis. RESULTS: mice. Similarly, treatment with a CX3CR1 antagonist did not attenuate the development of HA. CONCLUSIONS: macrophage recruitment during experimental HA, the CX3CL1-CX3CR1 axis is dispensable for the pathogenesis of acute hemophilic synovitis in this mouse model of severe hemophilia A.
No takes yet. Share an insight, caveat, or question.
Lawrence et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: